| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |